These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 32562718

  • 1. Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice.
    Watt G, Chesworth R, Przybyla M, Ittner A, Garner B, Ittner LM, Karl T.
    Pharmacol Biochem Behav; 2020 Sep; 196():172970. PubMed ID: 32562718
    [Abstract] [Full Text] [Related]

  • 2. Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice.
    Kreilaus F, Przybyla M, Ittner L, Karl T.
    Behav Brain Res; 2022 May 03; 425():113812. PubMed ID: 35202719
    [Abstract] [Full Text] [Related]

  • 3. Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy.
    Watt G, Przybyla M, Zak V, van Eersel J, Ittner A, Ittner LM, Karl T.
    Neuroscience; 2020 Apr 01; 431():166-175. PubMed ID: 32058066
    [Abstract] [Full Text] [Related]

  • 4. Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice.
    Watt G, Shang K, Zieba J, Olaya J, Li H, Garner B, Karl T.
    J Alzheimers Dis; 2020 Apr 01; 74(3):937-950. PubMed ID: 32116258
    [Abstract] [Full Text] [Related]

  • 5. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
    Kreilaus F, Masanetz R, Watt G, Przybyla M, Ittner A, Ittner L, Karl T.
    Behav Brain Res; 2021 Jan 15; 397():112943. PubMed ID: 33017638
    [Abstract] [Full Text] [Related]

  • 6. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
    Cheng D, Spiro AS, Jenner AM, Garner B, Karl T.
    J Alzheimers Dis; 2014 Jan 15; 42(4):1383-96. PubMed ID: 25024347
    [Abstract] [Full Text] [Related]

  • 7. Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.
    Cheng D, Low JK, Logge W, Garner B, Karl T.
    Psychopharmacology (Berl); 2014 Aug 15; 231(15):3009-17. PubMed ID: 24577515
    [Abstract] [Full Text] [Related]

  • 8. Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice.
    Coles M, Watt G, Kreilaus F, Karl T.
    Front Pharmacol; 2020 Aug 15; 11():587604. PubMed ID: 33424597
    [Abstract] [Full Text] [Related]

  • 9. Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice.
    van der Hoven J, van Hummel A, Przybyla M, Asih PR, Gajwani M, Feiten AF, Ke YD, Ittner A, van Eersel J, Ittner LM.
    Sci Rep; 2020 Aug 14; 10(1):13845. PubMed ID: 32796905
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J, Sinclair D, Sebree T, Bonn-Miller M, Gutterman D, Siegel S, Karl T.
    Pharmacol Biochem Behav; 2019 Jun 14; 181():93-100. PubMed ID: 31063743
    [Abstract] [Full Text] [Related]

  • 11. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.
    van Eersel J, Stevens CH, Przybyla M, Gladbach A, Stefanoska K, Chan CK, Ong WY, Hodges JR, Sutherland GT, Kril JJ, Abramowski D, Staufenbiel M, Halliday GM, Ittner LM.
    Neuropathol Appl Neurobiol; 2015 Dec 14; 41(7):906-25. PubMed ID: 25763777
    [Abstract] [Full Text] [Related]

  • 12. Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.
    Osborne AL, Solowij N, Babic I, Huang XF, Weston-Green K.
    Neuropsychopharmacology; 2017 Jun 14; 42(7):1447-1457. PubMed ID: 28230072
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse model.
    Chesworth R, Cheng D, Staub C, Karl T.
    Front Pharmacol; 2022 Jun 14; 13():931384. PubMed ID: 36238565
    [Abstract] [Full Text] [Related]

  • 14. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Jun 14; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 15. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CAF, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR.
    Acta Neuropathol; 2019 Dec 14; 138(6):913-941. PubMed ID: 31414210
    [Abstract] [Full Text] [Related]

  • 16. In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.
    Watt G, Karl T.
    Front Pharmacol; 2017 Dec 14; 8():20. PubMed ID: 28217094
    [Abstract] [Full Text] [Related]

  • 17. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J, Giménez-Llort L, Valero J, Miñano A, Rábano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA.
    Biol Psychiatry; 2010 Mar 15; 67(6):513-21. PubMed ID: 19664757
    [Abstract] [Full Text] [Related]

  • 18. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T, Schroeder JP, Rorabaugh JM, Liles LC, Lah JJ, Levey AI, Weinshenker D.
    J Neurosci; 2018 Jan 03; 38(1):74-92. PubMed ID: 29133432
    [Abstract] [Full Text] [Related]

  • 19. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
    Osborne AL, Solowij N, Babic I, Lum JS, Huang XF, Newell KA, Weston-Green K.
    Brain Behav Immun; 2019 Oct 03; 81():574-587. PubMed ID: 31326506
    [Abstract] [Full Text] [Related]

  • 20. Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning.
    Uhernik AL, Montoya ZT, Balkissoon CD, Smith JP.
    Neurobiol Learn Mem; 2018 Mar 03; 149():68-76. PubMed ID: 29432803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.